Fellowship · Rochester, NY
Sponsored by University of Rochester Medicine
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.
JAMA oncology · 2022 · 303 citations · Krisztina Hanley
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
The Lancet. Infectious diseases · 2022 · 91 citations · Mark Stoler
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2023 · 79 citations · Krisztina Hanley
Cervical Cancer Screening Recommendations: Now and for the Future.
Healthcare (Basel, Switzerland) · 2023 · 38 citations · Mark Stoler
Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial.
International journal of cancer · 2022 · 61 citations · Mark Stoler
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety.
Pediatrics · 2023 · 39 citations · Mark Stoler
Human papillomavirus genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
American journal of obstetrics and gynecology · 2024 · 19 citations · Mark Stoler
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years.
Human vaccines & immunotherapeutics · 2022 · 32 citations · Mark Stoler